
Victoria Wang, MD, discusses updated ASCCP recommendations for post-treatment monitoring of high-grade dysplasia and the importance of identifying high-risk patients early.
Victoria Wang, MD, is a gynecology oncology fellow at Brigham & Women's Hospital.